{
  "docId": "019dd923-605c-759f-b6b1-8a44d3a61b51",
  "docSlug": "bi-63f7eac6db4816a6",
  "documentTitle": "Pitch deck Georgiamune used to raise $75 million from General Catalyst",
  "authorId": "Pitchdecks",
  "authorName": "Georgiamune",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.777,
  "pageNumber": 9,
  "pageCount": 20,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "overcrowded",
  "nDataPoints": 3,
  "notes": "The slide uses a split-layout design with a dark left panel for the thesis and a white right panel for supporting metrics and the call to action.",
  "elementsJson": [
    "action_title",
    "big_number",
    "paragraph",
    "icon_grid"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-605c-759f-b6b1-8a44d3a61b51/9",
  "deckHref": "/decks/019dd923-605c-759f-b6b1-8a44d3a61b51",
  "deckJsonHref": "/decks/019dd923-605c-759f-b6b1-8a44d3a61b51.json",
  "deckAnchorHref": "/decks/019dd923-605c-759f-b6b1-8a44d3a61b51#slide-9",
  "components": [
    {
      "bbox": {
        "h": 0.1,
        "w": 0.38,
        "x": 0.57,
        "y": 0.75
      },
      "kind": "callout",
      "text": "A novel approach is needed to overcome checkpoint resistance to increase response rates and survival in cancer patients",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ebecad5b-ed64-4efd-a607-9150d675deb3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.08,
        "x": 0.43,
        "y": 0.1
      },
      "kind": "metric",
      "text": "+18",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b4d3bae5-ba1e-41e2-a30c-cfb00bc1344c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.08,
        "x": 0.43,
        "y": 0.48
      },
      "kind": "metric",
      "text": ">85%",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bdcb75d7-a362-4795-bbbd-9bdfce195242",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.08,
        "x": 0.43,
        "y": 0.28
      },
      "kind": "metric",
      "text": "$33B",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fd774274-b671-4246-912b-89cdf4816427",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "ICL failure rate: >85%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-bb7f-7799-a41b-bea26c7d530f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.38,
        "x": 0.57,
        "y": 0.28
      },
      "kind": "paragraph",
      "text": "Current global sales are estimated to be $33B, representing a multibillion-dollar opportunity",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "84fb0074-82c5-47ad-98fe-e4e9d9f32b81",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.38,
        "x": 0.57,
        "y": 0.48
      },
      "kind": "paragraph",
      "text": "ICIs alleviate checkpoint-mediated immunosuppression, but fail to activate the antitumor immune response. This failure is thought to drive ICI failure in >85% of treated cancer patients",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e0de3d2e-6267-405c-a431-0f1af8268b28",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.38,
        "x": 0.57,
        "y": 0.1
      },
      "kind": "paragraph",
      "text": "Since their first approval in 2011, immune checkpoint inhibitors (ICIs) have been widely approved for more than 18 different cancer types, covering nearly half of all cancer cases in the US",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f5e64845-3409-43ee-b4f9-c531e2d702a9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.3,
        "x": 0.08,
        "y": 0.18
      },
      "kind": "title",
      "text": "Checkpoint Inhibitors have shifted the cancer therapy paradigm, But Are Ineffective for Many Patients",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0196f284-5125-4c37-8db8-16823bccb981",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "4a31aeb1-d852-4d46-8bdb-e5cd64504913",
      "evidence": "The slide presents a clear problem statement, challenge, and call to action, which are key components of a problem statement canvas.",
      "confidence": 0.7
    },
    {
      "name": "SCQA Framework",
      "slug": "scqa-framework",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "298a3eab-ce56-4f59-ba2c-d8fa16ee3115",
      "evidence": "The slide follows a SCQA (Situation, Complication, Question, Answer) framework, which is a common storytelling structure.",
      "confidence": 0.6
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 10,
      "from": 9,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "59e9c480-d1b7-4ecd-b65c-59fa713085fc",
      "evidence": "The deck presents the limitations of current treatments on pages 9 and 10",
      "position": 0,
      "objective": "Highlight the limitations of current treatments",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}